Skip to content
10-Q

Quarterly Report

American CryoStem Corporation

0001019056-21-000132

← back to feed
Filed
Feb 16, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Feb 9, 2021 60.09M sh
Current Liabilities Q1 2021 · Dec 31, 2020 $1.05M
Current Liabilities Q1 2021 · Sep 30, 2020 $1.05M
Total Liabilities Q1 2021 · Dec 31, 2020 $1.95M
Total Liabilities Q1 2021 · Sep 30, 2020 $1.9M
Current Assets Q1 2021 · Dec 31, 2020 $692.39K
Current Assets Q1 2021 · Sep 30, 2020 $567.16K
Total Assets Q1 2021 · Dec 31, 2020 $1.59M
Total Assets Q1 2021 · Sep 30, 2020 $1.48M
Operating Cash Flow Q1 2021 · Dec 31, 2019 −$268.57K
Cash And Equivalents Q1 2021 · Dec 31, 2019 $82.21K
Cash And Equivalents Q1 2021 · Sep 30, 2019 $23.8K
Stockholders Equity restated Q1 2021 · Dec 31, 2019 −$1.29M
Stockholders Equity Q1 2021 · Sep 30, 2019 −$1.24M
Net Income Q1 2021 · Dec 31, 2019 −$271.86K
Operating Income Q1 2021 · Dec 31, 2019 −$89.94K
Gross Profit Q1 2021 · Dec 31, 2019 $127.94K
Cost Of Revenue Q1 2021 · Dec 31, 2019 $5.19K
Revenue Q1 2021 · Dec 31, 2019 $133.13K